Developer docs
API playgroundTry for free, no card

Search company profiles

Reach Separations

Full company profile

uuid0026rwi

Namestring
Reach Separations
Legal namestring
Reach Separations Ltd
Company typeenum
Private
Founded yearint
2011
Descriptiontext

Reach Separations is a UK-based specialist chromatography Contract Research Organization (CRO) that provides analysis and purification services for small molecules, with particular strength in chiral separations. Founded in 2011 in Nottingham and now operating as part of the CatSci Group following a June 2024 acquisition backed by Keensight Capital, the company operates laboratory facilities in Nottingham (BioCity) and Strasbourg, France (opened June 2022), with a total headcount of 14 as of 2024. Services span discovery chromatography, large-scale Supercritical Fluid Chromatography (SFC) chiral purification, achiral separations, impurity isolation, and analytical services including Experimental Polar Surface Area (EPSA), ChromLogD, stability studies, and specialized purification of PROTACs/molecular glues, oligonucleotides, and peptides from milligrams to kilograms scale. The core technology platform combines HPLC and SFC side by side, supported by an automated chiral screening system capable of testing 150+ conditions in under 24 hours and achieving a documented 98% chiral separation success rate.

The company's client base exceeds 150 distinct organizations, accumulated over a decade based on signed confidentiality agreements, including pharmaceutical, biotechnology, agrochemical, fine chemical, natural product, and medicinal cannabis companies across the UK and Europe, with occasional engagements in South Africa and South Korea. Reach generates revenue through project-based professional services engagements, with pricing tied to scope and scale rather than disclosed publicly; salaries disclosed for hiring provide some indirect signal (Graduate Chemist at £24-27k, Chromatography Expert at £30-45k). Go-to-market is sales-led via a dedicated business development team (Managing Director, Business Development Director, Global Head of Business Development, and associates) and built on industry conference attendance, scientific content marketing, and supporting partnerships with complementary providers (NMR Peak, MINAKEM, SFE Process, BioTools, University of Southampton Mass Spectrometry, and SIM GmbH in Germany). The June 2024 acquisition by CatSci Ltd is positioned as a strategic move to offer end-to-end separation science support from discovery through to GMP manufacture, with Reach retaining its brand identity and operating model under the CatSci Group.

Short descriptiontext

Reach Separations is a UK-based chromatography CRO specializing in chiral and achiral separations, analytical services, and purification of small molecules, PROTACs, oligonucleotides, and peptides for pharmaceutical, agrochemical, and fine chemical clients across Europe, now operating as part of the CatSci Group.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersNottingham, United Kingdom
HQ citystring
Nottingham
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
chromatography services, chiral separations, HPLC purification, SFC purification, pharmaceutical CRO
Industry3 codes
PRIMARYHLAGAHAE
Chiral / Asymmetric Synthesis & Complex Chemistry Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
SECONDARYHLAAAJAB
Downstream Processing & Purification Technologies (chromatography, filtration, centrifugation)
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)
SECONDARYHLAGAIAA
Analytical Instruments & Chromatography Systems
NAICS code1 code
  • Analytical Laboratory Instrument Manufacturing334516
SIC code1 code
  • Services-Misc Health & Allied Services, Nec8090
Product category
Pharmaceutical CRO Chromatography Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Chromatography Services
TypeProfessional Services
Description

CRO services providing chromatography for analysis and purification. Services span discovery chromatography, large-scale SFC chiral purification, impurity isolation, and analytical services. Project-based engagement with pharmaceutical, agrochemical, and fine chemical clients.

reachseparations.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales
Pricing details2 tiers
1Graduate Chemist salary range
ModelOtherBilling cadenceAnnual
Notes

Starting salary £24,500 to £27,000 dependent on relevant work experience

reachseparations.com
2Chromatography Expert salary range
ModelOtherBilling cadenceAnnual
Notes

Starting salary £30,000 to £45,000 dependent on areas of expertise and experience

reachseparations.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Reach Separations provides chromatography services for the analysis and purification of small molecules, combining High-Performance Liquid Chromatography (HPLC) and Supercritical Fluid Chromatography (SFC) platforms. Service offerings include chiral separations, achiral separations, large-scale SFC purification, impurity isolation, and specialized purification for PROTACs, oligonucleotides, and peptides, delivered to pharmaceutical, agrochemical, and fine chemical clients across the UK and Europe.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Samples returned within 5 working days for quantities of 5g or less
+2 more records
Product overview1 text field

Reach Separations is a chromatography service provider offering a comprehensive suite of separation science services for the pharmaceutical, agrochemical, and fine chemical sectors. The core technology platform combines High-Performance Liquid Chromatography (HPLC) and Supercritical Fluid Chromatography (SFC) techniques. The service portfolio includes: (1) Chiral Separations and Achiral Separations as foundational services; (2) Analytical Services encompassing UHPLC-MS, SFC-MS, QC, EPSA, ChromLogD, and Stability Studies; (3) Specialized Purification services for PROTACs & Molecular Glues (bRo5), Oligonucleotides, and Peptides; and (4) Large Scale purification capabilities for chiral compounds and impurity isolation. Services span from discovery scale (milligrams) through development (kilograms), with facilities in Nottingham, UK and Strasbourg, France.

Product and service11 records
1Chiral Separations
CategoryCore Service
Description

Chiral chromatography services for analysis and purification of racemates, ranging from enantiomeric excess (EE) determinations through to purification of hundreds of grams of racemate, utilizing automated screening systems achieving a 98% success rate.

2Achiral Separations
CategoryCore Service
Description

LC-MS and SFC-MS analysis, method development, and orthogonal purity analysis including multi-component resolutions, reference standard generation, plate purifications, and single sample purification from 5mg to 500g.

3Analytical Services
CategoryCore Service
Description

Suite of analytical services including Waters HClass UPLC, Agilent 1290 UHPLC, Thermo Vanquish UHPLC, Waters UPC2 SFC, Agilent Infinity 2 1260 SFC, and Agilent 8860 GC, with QC via LCMS, EPSA, ChromLogD, and stability studies.

4PROTACs & Molecular Glue Purification
CategorySpecialized Service
Description

Beyond-Rule-of-5 (bRo5) purification services for PROTACs and molecular glues using Supercritical Fluid Chromatography (SFC) and Reverse Phase HPLC, achieving up to 99% purity.

5Oligonucleotide Drug Substances Purification
CategorySpecialized Service
Description

Ion-pair Reverse Phase HPLC purification of oligonucleotide drug substances at scales from milligrams to over 100g, ensuring high purity levels for drug development and commercialization.

6Peptide Purification
CategorySpecialized Service
Description

Peptide purification using HPLC and SFC, achieving purity levels exceeding 98%, with scalable solutions from milligram to kilogram scale in dedicated large-scale laboratory facilities.

7Experimental Polar Surface Area (EPSA)
CategoryAnalytical Service
Description

High-throughput SFC-based methodology to measure compound polar surface area, a significant factor in permeability assessment for beyond-Rule-of-5 compounds such as PROTACs and cyclic peptides.

8ChromLogD
CategoryAnalytical Service
Description

Lipophilicity measurement using reverse-phase chromatography to simulate octanol/water equilibrium, providing indicative lipophilicity values at various pH levels with high throughput.

9Stability Studies
CategoryAnalytical Service
Description

Chemical and chiral stability studies assessing molecule behavior under various temperatures and pH conditions across multiple time points, adapted to match client requirements.

10Large Scale SFC for Chiral Purification
CategoryScale-up Service
Description

Large-scale supercritical fluid chromatography for processing hundreds of grams of racemate per week, utilizing automated evaporation capabilities for chiral scale-up projects.

11Impurity Isolation
CategorySpecialized Service
Description

Isolation of pure samples of unknown impurities from hundreds of grams of crude material, including elucidation packages with MS-MS and NMR data through partner collaborations.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-06-24
Description

CatSci Ltd acquired Reach Separations in June 2024, creating an integrated separation science offering. The acquisition enables end-to-end coverage from discovery through to GMP manufacture, combining Reach's chromatography expertise with CatSci's CMC capabilities. Reach operates as part of the CatSci Group while maintaining its brand identity.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-11-28
Description

Prior to acquisition, CatSci and Reach announced a strategic partnership in November 2023 to offer end-to-end analytical support from discovery to manufacture. The partnership provided customers access to Reach's expert automated chromatography capabilities combined with CatSci's GMP method development and validation services.

3NMR Peak
Strategic tierSupportingTypeImplementation/ SI/ Consulting Partner
Description

NMR Peak, founded by Torren Peakman in 2011, offers small molecule NMR expertise including structure determination and physical properties measurement for pharmaceutical and biotech clients. Supports Reach's impurity isolation services with NMR characterization.

reachseparations.com
Strategic tierSupportingTypeTechnology or Integration
Description

Dr Julie Herniman and Professor John Langley head up the facility providing mass spectrometry expertise. Combined nearly 60 years of chromatography and mass spectrometry experience supporting industry clients.

Strategic tierSupportingTypeTechnology or Integration
Description

BioTools provides VCD (Vibrational Circular Dichroism) for chiral structural elucidation. Life sciences structural characterisation company providing molecular structure information for chiral small molecules.

Strategic tierSupportingTypeStrategic or Co-development Partner
Description

MINAKEM specializes in APIs, HPAPIs and CMC commercial custom manufacturing with cGMP capabilities. Has 50, 110, and 300mm HPLC columns for GMP high potent purification, supporting scale-up from Reach's services.

Strategic tierSupportingTypeTechnology or Integration
Description

SFE Process provides Supercritical Fluid Extraction equipment. Partnership established for offering purification of extracts by SFC and supporting production scale SFC. The instrument can operate with 100% CO2 and utilises a recycle loop for green chemistry.

Strategic tierSupportingTypeChannel Partner/ Reseller/ Distributor
Description

SIM GmbH is a partner company in Germany for SFC and analytical Prep SFC. Stéphane Dubant supported SIM at Analytica 2024 conference in Munich to discuss SFC capabilities.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global CRO/testing giant with broad chromatography, chiral and analytical services across pharma and chemicals; competes with Reach as a one-stop-shop incumbent, offering Reach's capabilities within a much wider service portfolio.

TypeBroad incumbent
Description

CDMO with strong chiral chemistry and API manufacturing expertise; comparable to Reach on chiral small-molecule work and partner MINAKEM-style scale-up, but with integrated GMP manufacturing and a global footprint.

TypeOthers
Description

Leading chromatography and SFC instrument manufacturer whose hardware and software underpin Reach's laboratory; an enabler/ecosystem participant rather than a direct competitor, and historically connected to founder Peter Ridgway's career at Thar/Waters.

TypeDirect peer
Description

UK-based discovery CRO serving pharma and biotech clients with medicinal chemistry, in vitro biology and DMPK; highly comparable to Reach in geography, customer mix (UK/European pharma, virtual pharma) and outsourcing model.

TypeBroad incumbent
Description

Global CRO/CDMO providing discovery chemistry, chromatography and process R&D to pharma and biotech; comparable to Reach on small-molecule separations and chiral services, with broader CMC and manufacturing scope.

TypeBroad incumbent
Description

Major chromatography columns and consumables provider, now part of Danaher, with growing services and applications support; adjacent competitor on chiral and SFC method development serving overlapping pharma customers.

TypeDirect peer
Description

Global leader in chiral chromatography columns, services and screening; the most direct competitor on chiral separations, with overlapping customers in pharma and agrochemicals and a similar focus on chiral method development and screening scale.

TypeDirect peer
Description

UK-based chromatography specialist providing HPLC columns, method development and analytical services; comparable to Reach on chromatography expertise and UK/European pharma customer base, though more focused on column products.

TypeBroad incumbent
Description

Large discovery and development CRO offering chemistry, chromatography and purification services; overlaps with Reach on pharma/biotech discovery clients and bundles similar capabilities into integrated programmes.

TypeDirect peer
Description

Specialist in preparative SFC systems and SFC-based purification services; competes head-to-head with Reach on SFC-driven chiral and achiral purification for drug discovery and process development customers.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Reach Separations

Pharmaceutical CRO Chromatography Servicesreachseparations.com

Reach Separations is a UK-based chromatography CRO specializing in chiral and achiral separations, analytical services, and purification of small molecules, PROTACs, oligonucleotides, and peptides for pharmaceutical, agrochemical, and fine chemical clients across Europe, now operating as part of the CatSci Group.

What Reach Separations does

Reach Separations is a UK-based specialist chromatography Contract Research Organization (CRO) that provides analysis and purification services for small molecules, with particular strength in chiral separations. Founded in 2011 in Nottingham and now operating as part of the CatSci Group following a June 2024 acquisition backed by Keensight Capital, the company operates laboratory facilities in Nottingham (BioCity) and Strasbourg, France (opened June 2022), with a total headcount of 14 as of 2024. Services span discovery chromatography, large-scale Supercritical Fluid Chromatography (SFC) chiral purification, achiral separations, impurity isolation, and analytical services including Experimental Polar Surface Area (EPSA), ChromLogD, stability studies, and specialized purification of PROTACs/molecular glues, oligonucleotides, and peptides from milligrams to kilograms scale. The core technology platform combines HPLC and SFC side by side, supported by an automated chiral screening system capable of testing 150+ conditions in under 24 hours and achieving a documented 98% chiral separation success rate.

The company's client base exceeds 150 distinct organizations, accumulated over a decade based on signed confidentiality agreements, including pharmaceutical, biotechnology, agrochemical, fine chemical, natural product, and medicinal cannabis companies across the UK and Europe, with occasional engagements in South Africa and South Korea. Reach generates revenue through project-based professional services engagements, with pricing tied to scope and scale rather than disclosed publicly; salaries disclosed for hiring provide some indirect signal (Graduate Chemist at £24-27k, Chromatography Expert at £30-45k). Go-to-market is sales-led via a dedicated business development team (Managing Director, Business Development Director, Global Head of Business Development, and associates) and built on industry conference attendance, scientific content marketing, and supporting partnerships with complementary providers (NMR Peak, MINAKEM, SFE Process, BioTools, University of Southampton Mass Spectrometry, and SIM GmbH in Germany). The June 2024 acquisition by CatSci Ltd is positioned as a strategic move to offer end-to-end separation science support from discovery through to GMP manufacture, with Reach retaining its brand identity and operating model under the CatSci Group.

Reach Separations firmographics

Firmographics
Name
Reach Separations
Legal name
Reach Separations Ltd
Website
https://reachseparations.com
Company type
Private
Founded year
2011
Operating status
Operating
Headcount range
11–50 employees
Short description
Reach Separations is a UK-based chromatography CRO specializing in chiral and achiral separations, analytical services, and purification of small molecules, PROTACs, oligonucleotides, and peptides for pharmaceutical, agrochemical, and fine chemical clients across Europe, now operating as part of the CatSci Group.
Ownership category
akta.pro rank

Reach Separations industry classification

Industry
Product category
Pharmaceutical CRO Chromatography Services
NAICS
Analytical Laboratory Instrument Manufacturing (334516)
SIC
Services-Misc Health & Allied Services, Nec (8090)
akta.pro industry
PRIMARYHLAGAHAE
Chiral / Asymmetric Synthesis & Complex Chemistry Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
SECONDARYHLAAAJAB
Downstream Processing & Purification Technologies (chromatography, filtration, centrifugation)
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)
SECONDARYHLAGAIAA
Analytical Instruments & Chromatography Systems

Keywords

  • Chromatography services
  • Chiral separations
  • HPLC purification
  • SFC purification
  • Pharmaceutical CRO

Where Reach Separations is headquartered

Location

Headquarters

HQ city
Nottingham
HQ country
United Kingdom
HQ region
Europe

Offices2 records

Markets served

Reach Separations business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

  1. Chromatography Services: CRO services providing chromatography for analysis and purification. Services span discovery chromatography, large-scale SFC chiral purification, impurity isolation, and analytical services. Project-based engagement with pharmaceutical, agrochemical, and fine chemical clients.

Pricing tiers

ModelBillingPrice
OtherAnnualGraduate Chemist salary range
OtherAnnualChromatography Expert salary range

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Reach Separations product offering

Product offering

Core offering

Reach Separations provides chromatography services for the analysis and purification of small molecules, combining High-Performance Liquid Chromatography (HPLC) and Supercritical Fluid Chromatography (SFC) platforms. Service offerings include chiral separations, achiral separations, large-scale SFC purification, impurity isolation, and specialized purification for PROTACs, oligonucleotides, and peptides, delivered to pharmaceutical, agrochemical, and fine chemical clients across the UK and Europe.

Product overview

Reach Separations is a chromatography service provider offering a comprehensive suite of separation science services for the pharmaceutical, agrochemical, and fine chemical sectors. The core technology platform combines High-Performance Liquid Chromatography (HPLC) and Supercritical Fluid Chromatography (SFC) techniques. The service portfolio includes: (1) Chiral Separations and Achiral Separations as foundational services; (2) Analytical Services encompassing UHPLC-MS, SFC-MS, QC, EPSA, ChromLogD, and Stability Studies; (3) Specialized Purification services for PROTACs & Molecular Glues (bRo5), Oligonucleotides, and Peptides; and (4) Large Scale purification capabilities for chiral compounds and impurity isolation. Services span from discovery scale (milligrams) through development (kilograms), with facilities in Nottingham, UK and Strasbourg, France.

Differentiator

Problem solved

Functional benefit

Products and services

  • Chiral Separations Chiral chromatography services for analysis and purification of racemates, ranging from enantiomeric excess (EE) determinations through to purification of hundreds of grams of racemate, utilizing automated screening systems achieving a 98% success rate.
  • Achiral Separations LC-MS and SFC-MS analysis, method development, and orthogonal purity analysis including multi-component resolutions, reference standard generation, plate purifications, and single sample purification from 5mg to 500g.
  • Analytical Services Suite of analytical services including Waters HClass UPLC, Agilent 1290 UHPLC, Thermo Vanquish UHPLC, Waters UPC2 SFC, Agilent Infinity 2 1260 SFC, and Agilent 8860 GC, with QC via LCMS, EPSA, ChromLogD, and stability studies.
  • PROTACs & Molecular Glue Purification Beyond-Rule-of-5 (bRo5) purification services for PROTACs and molecular glues using Supercritical Fluid Chromatography (SFC) and Reverse Phase HPLC, achieving up to 99% purity.
  • Oligonucleotide Drug Substances Purification Ion-pair Reverse Phase HPLC purification of oligonucleotide drug substances at scales from milligrams to over 100g, ensuring high purity levels for drug development and commercialization.
  • Peptide Purification Peptide purification using HPLC and SFC, achieving purity levels exceeding 98%, with scalable solutions from milligram to kilogram scale in dedicated large-scale laboratory facilities.
  • Experimental Polar Surface Area (EPSA) High-throughput SFC-based methodology to measure compound polar surface area, a significant factor in permeability assessment for beyond-Rule-of-5 compounds such as PROTACs and cyclic peptides.
  • ChromLogD Lipophilicity measurement using reverse-phase chromatography to simulate octanol/water equilibrium, providing indicative lipophilicity values at various pH levels with high throughput.
  • Stability Studies Chemical and chiral stability studies assessing molecule behavior under various temperatures and pH conditions across multiple time points, adapted to match client requirements.
  • Large Scale SFC for Chiral Purification Large-scale supercritical fluid chromatography for processing hundreds of grams of racemate per week, utilizing automated evaporation capabilities for chiral scale-up projects.
  • Impurity Isolation Isolation of pure samples of unknown impurities from hundreds of grams of crude material, including elucidation packages with MS-MS and NMR data through partner collaborations.

Quantifiable outcome

  • Samples returned within 5 working days for quantities of 5g or less
  • +2 more outcomes

Companies that use Reach Separations

Customer profile

Named customers4 records

Segments5 records

Ideal customer profiles3 records

Reach Separations technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Reach Separations partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered core and supporting.

  • CatSci LtdcoreStrategic or Co-development Partner · 24 June 2024CatSci Ltd acquired Reach Separations in June 2024, creating an integrated separation science offering. The acquisition enables end-to-end coverage from discovery through to GMP manufacture, combining Reach's chromatography expertise with CatSci's CMC capabilities. Reach operates as part of the CatSci Group while maintaining its brand identity.
  • CatSci LtdcoreStrategic or Co-development Partner · 28 November 2023Prior to acquisition, CatSci and Reach announced a strategic partnership in November 2023 to offer end-to-end analytical support from discovery to manufacture. The partnership provided customers access to Reach's expert automated chromatography capabilities combined with CatSci's GMP method development and validation services.
  • NMR PeaksupportingImplementation/ SI/ Consulting PartnerNMR Peak, founded by Torren Peakman in 2011, offers small molecule NMR expertise including structure determination and physical properties measurement for pharmaceutical and biotech clients. Supports Reach's impurity isolation services with NMR characterization.
  • University of Southampton Mass Spectrometry FacilitysupportingTechnology or IntegrationDr Julie Herniman and Professor John Langley head up the facility providing mass spectrometry expertise. Combined nearly 60 years of chromatography and mass spectrometry experience supporting industry clients.
  • BiotoolssupportingTechnology or IntegrationBioTools provides VCD (Vibrational Circular Dichroism) for chiral structural elucidation. Life sciences structural characterisation company providing molecular structure information for chiral small molecules.
  • MINAKEMsupportingStrategic or Co-development PartnerMINAKEM specializes in APIs, HPAPIs and CMC commercial custom manufacturing with cGMP capabilities. Has 50, 110, and 300mm HPLC columns for GMP high potent purification, supporting scale-up from Reach's services.
  • SFE ProcesssupportingTechnology or IntegrationSFE Process provides Supercritical Fluid Extraction equipment. Partnership established for offering purification of extracts by SFC and supporting production scale SFC. The instrument can operate with 100% CO2 and utilises a recycle loop for green chemistry.
  • SIM GmbHsupportingChannel Partner/ Reseller/ DistributorSIM GmbH is a partner company in Germany for SFC and analytical Prep SFC. Stéphane Dubant supported SIM at Analytica 2024 conference in Munich to discuss SFC capabilities.

Scale indicators6 records

Recent moves8 records

Expansion highlights5 records

Reach Separations competitors and assessment

Company assessment

Broad incumbents

  • Eurofins Scientific: Global CRO/testing giant with broad chromatography, chiral and analytical services across pharma and chemicals; competes with Reach as a one-stop-shop incumbent, offering Reach's capabilities within a much wider service portfolio.
  • Hovione: CDMO with strong chiral chemistry and API manufacturing expertise; comparable to Reach on chiral small-molecule work and partner MINAKEM-style scale-up, but with integrated GMP manufacturing and a global footprint.
  • Sai Life Sciences: Global CRO/CDMO providing discovery chemistry, chromatography and process R&D to pharma and biotech; comparable to Reach on small-molecule separations and chiral services, with broader CMC and manufacturing scope.
  • Phenomenex (Danaher): Major chromatography columns and consumables provider, now part of Danaher, with growing services and applications support; adjacent competitor on chiral and SFC method development serving overlapping pharma customers.
  • Charles River Laboratories: Large discovery and development CRO offering chemistry, chromatography and purification services; overlaps with Reach on pharma/biotech discovery clients and bundles similar capabilities into integrated programmes.

Others

  • Waters Corporation: Leading chromatography and SFC instrument manufacturer whose hardware and software underpin Reach's laboratory; an enabler/ecosystem participant rather than a direct competitor, and historically connected to founder Peter Ridgway's career at Thar/Waters.

Direct peers

  • Sygnature Discovery: UK-based discovery CRO serving pharma and biotech clients with medicinal chemistry, in vitro biology and DMPK; highly comparable to Reach in geography, customer mix (UK/European pharma, virtual pharma) and outsourcing model.
  • Chiral Technologies (Daicel): Global leader in chiral chromatography columns, services and screening; the most direct competitor on chiral separations, with overlapping customers in pharma and agrochemicals and a similar focus on chiral method development and screening scale.
  • Hichrom: UK-based chromatography specialist providing HPLC columns, method development and analytical services; comparable to Reach on chromatography expertise and UK/European pharma customer base, though more focused on column products.
  • Sepiatec: Specialist in preparative SFC systems and SFC-based purification services; competes head-to-head with Reach on SFC-driven chiral and achiral purification for drug discovery and process development customers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Reach Separations social profiles

Digital presence

Reach Separations financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Reach Separations leadership team

Management profile

Number of profiles

Profiles7 records

Reach Separations funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Reach Separations M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Reach Separations

What does Reach Separations do?

Reach Separations provides chromatography services for the analysis and purification of small molecules, combining High-Performance Liquid Chromatography (HPLC) and Supercritical Fluid Chromatography (SFC) platforms. Service offerings include chiral separations, achiral separations, large-scale SFC purification, impurity isolation, and specialized purification for PROTACs, oligonucleotides, and peptides, delivered to pharmaceutical, agrochemical, and fine chemical clients across the UK and Europe.

Is Reach Separations a public or private company?

Reach Separations is a private company. It is classified as corporate owned and is currently operating.

When was Reach Separations founded?

Reach Separations was founded in 2011. It employs 11 to 50 people.

Where is Reach Separations based?

Reach Separations is headquartered in Nottingham, United Kingdom, in the Europe region.

How does Reach Separations make money?

One revenue line is on record: chromatography Services.

Who are Reach Separations's main competitors?

Broad incumbents on record are Eurofins Scientific, Hovione, Sai Life Sciences, Phenomenex (Danaher) and Charles River Laboratories. Waters Corporation is listed as an others. Direct peers are Sygnature Discovery, Chiral Technologies (Daicel), Hichrom and Sepiatec.

Does Reach Separations have an API?

No public API is recorded for Reach Separations.

What industry is Reach Separations in?

Reach Separations's product category is Pharmaceutical CRO Chromatography Services. Its primary akta.pro industry code is HLAGAHAE, Chiral / Asymmetric Synthesis & Complex Chemistry Services, with a secondary code of HLAAAJAB, Downstream Processing & Purification Technologies (chromatography, filtration, centrifugation). Its NAICS code is 334516 and its SIC code is 8090.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
InsidermediaCatSci makes strategic acquisition of Reach SeparationsCatSci has acquired Reach Separations to enhance its chromatographic services for global customers. This strategic acquisition is aimed at improving CatSci's capabilities in Chemistry, Manufacturing and Controls (CMC) and marks a significant milestone in its growth strategy. The integration is expected to facilitate better analytical development from discovery to manufacture, benefiting customers by providing comprehensive services.CatsciCatSci Announces-Acquisition of Reach SeparationsCatSci Ltd announced its acquisition of Reach Separations, a chromatography provider specializing in the analysis and purification of therapeutics. This acquisition, supported by Keensight Capital, aims to enhance CatSci's services for global customers in chromatographic analysis from discovery to manufacture. The integration is expected to strengthen both companies' capabilities in handling complex analytical challenges and regulatory demands.SpecchemonlineCatSci buys Reach SeparationsDrug development services supplier CatSci has acquired its UK-based competitor Reach Separations, with the transaction supported by private equity manager Keensight Capital. The acquisition involves the full transfer and integration of Reach Separations' laboratories in the UK and France, expanding CatSci's chromatographic service capabilities.ReachseparationsCatSci announces strategic acquisition of Reach Separations to offer end-to-end separation science support from discovery to manufacture, with the support of Keensight CapitalCatSci Ltd has acquired Reach Separations, a specialist chromatography provider, to expand its end-to-end separation science capabilities from discovery through to manufacture. The transaction was supported by private equity manager Keensight Capital and integrates Reach's SFC and HPLC technologies into CatSci's CMC offerings.